Skip to main content

RETRACTION article

Front. Immunol., 04 September 2023
Sec. Autoimmune and Autoinflammatory Disorders
Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1285591

Retraction: Dysregulation of survivin-targeting microRNAs in autoimmune diseases: new perspectives for novel therapies

This article is a retraction of:

  1. RETRACTED: Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies

    1. Read original article
Frontiers Editorial Office* Frontiers Editorial Office*

    A Retraction of the Review Article
    Dysregulation of survivin-targeting microRNAs in autoimmune diseases: new perspectives for novel therapies

    by Shomali N, Suliman Maashi M, Baradaran B, Daei Sorkhabi A, Sarkesh A, Mohammadi H, Hemmatzadeh M, Marofi F, Sandoghchian Shotorbani S and Jarahian M (2022). Front. Immunol. 13:839945. doi: 10.3389/fimmu.2022.839945

    The journal retracts the 2022 article cited above.

    Following publication, concerns were raised regarding the contributions of the authors of the article. Our investigation, conducted in accordance with Frontiers policies, confirmed a serious breach of our authorship policies and of publication ethics; the article is therefore retracted.

    This retraction was approved by the Chief Editors of Frontiers in Immunology and the Chief Executive Editor of Frontiers. The authors do not agree to this retraction.

    Citation: Frontiers Editorial Office (2023) Retraction: Dysregulation of survivin-targeting microRNAs in autoimmune diseases: new perspectives for novel therapies. Front. Immunol. 14:1285591. doi: 10.3389/fimmu.2023.1285591

    Received: 30 August 2023; Accepted: 30 August 2023;
    Published: 04 September 2023.

    Approved by:

    Luigi Daniele Notarangelo, National Institute of Allergy and Infectious Diseases (NIH), United States

    Copyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    *Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.